Cited by 72Cardiovascular Issues in PregnancyCardiac electrophysiology and arrhythmiasPregnancy and Medication Impact

Antiarrhythmic drugs in pregnancy

Joglar, Jose A., Page, Richard L.·2001·Current Opinion in Cardiology

Abstract

During pregnancy a number of rhythm disturbances can occur in both the mother and fetus; these may range from benign ectopy to life-threatening arrhythmias. With a clear understanding of the maternal hemodynamic changes associated with pregnancy, and the appropriate antiarrhythmic therapies available, almost all such cases can be treated successfully. Although no drug is completely safe, most are well tolerated and can be given with relatively low risk. Drug therapy should be avoided during the first trimester of pregnancy if possible and drugs with the longest record of safety should be used as first-line therapy. Conservative therapies should be used when appropriate. Several drug options exist for most maternal and fetal arrhythmias.

Integrity signals

Registry

Crossref · 10.1097/00001573-200101000-00006

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Authors
Joglar, J. A., & Page, R. L.
Affiliations
The University of Texas at Dallas (US)
Corresponding author
Page, Richard L.
Venue
Current Opinion in Cardiology
Published
2001-01
Volume
16
Issue
1
Pages
40-45
ISSN
0268-4705 (ISSN-L)
OpenAlex
W2001933328
Cited by
72
References
65
Citations by year
2025: 1 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 1 · 2018: 3 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 2 · 2013: 3 · 2012: 7
FWCI
0.56
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Issues in Pregnancy
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
antiarrhythmic drugs, pregnancy, fetal arrhythmia, drug safety in pregnancy, first trimester, conservative treatment, drug selection
MeSH terms
Adrenergic beta-Antagonists, Amiodarone, Anti-Arrhythmia Agents, Arrhythmias, Cardiac, Female, Heart Conduction System, Humans, Pregnancy, Pregnancy Complications, Cardiovascular, Potassium Channel Blockers, Sodium Channel Blockers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review